207 related articles for article (PubMed ID: 3885584)
1. Inotropic agents in the treatment of cardiogenic shock.
Mueller HS
World J Surg; 1985 Feb; 9(1):3-10. PubMed ID: 3885584
[No Abstract] [Full Text] [Related]
2. Inotropic agents in the treatment of cardiogenic shock.
Bourdarias JP; Dubourg O; Gueret P; Ferrier A; Bardet J
Pharmacol Ther; 1983; 22(1):53-79. PubMed ID: 6361798
[No Abstract] [Full Text] [Related]
3. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
El Mokhtari NE; Arlt A; Meissner A; Lins M
Eur J Med Res; 2007 Nov; 12(11):563-7. PubMed ID: 18024265
[TBL] [Abstract][Full Text] [Related]
4. Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
Mueller H; Ayres SM; Giannelli S; Conklin EF; Mazzara JT; Grace WJ
Circulation; 1972 Feb; 45(2):335-51. PubMed ID: 5009478
[No Abstract] [Full Text] [Related]
5. Newer catecholamines for treatment of heart failure and shock: an update on dopamine and a first look at dobutamine.
Goldberg LI; Hsieh YY; Resnekov L
Prog Cardiovasc Dis; 1977; 19(4):327-40. PubMed ID: 12536
[No Abstract] [Full Text] [Related]
6. [Comparative studies on the hemodynamic effects of dobutamine, dopamine, and isoproterenol in dogs in experimental shock (author's transl)].
Matsumura S; Morishige E; Uno O; Ueda M
Nihon Yakurigaku Zasshi; 1980 Mar; 76(2):131-41. PubMed ID: 7399367
[TBL] [Abstract][Full Text] [Related]
7. Cardiogenic shock: therapeutic implications of altered myocardial energy balance.
Kones RJ
Angiology; 1974 May; 25(5):317-33. PubMed ID: 4150913
[No Abstract] [Full Text] [Related]
8. Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy.
McGhie AI; Golstein RA
Chest; 1992 Nov; 102(5 Suppl 2):626S-632S. PubMed ID: 1424938
[TBL] [Abstract][Full Text] [Related]
9. Inotropic therapy for cardiac low output syndrome: comparison of hemodynamic effects of dopamine/dobutamine versus dopamine/dopexamine.
El Mokhtari NE; Arlt A; Meissner A; Lins M
Eur J Med Res; 2008 Oct; 13(10):459-63. PubMed ID: 19008172
[TBL] [Abstract][Full Text] [Related]
10. Cardiogenic shock.
Rackley CE; Russell RO; Mantle JA; Rogers WJ
Cardiovasc Clin; 1981; 11(3):15-24. PubMed ID: 7214388
[TBL] [Abstract][Full Text] [Related]
11. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
12. [Application of non-glycoside inotropic agents in newborn infants].
Umans-Eckenhausen MA; Terlouw JF; Szatmari A; van den Anker JN
Tijdschr Kindergeneeskd; 1993 Feb; 61(1):13-20. PubMed ID: 8493697
[TBL] [Abstract][Full Text] [Related]
13. Shock in myocardial infarction--medical treatment.
Kuhn LA
Am J Cardiol; 1970 Dec; 26(6):578-87. PubMed ID: 4938984
[No Abstract] [Full Text] [Related]
14. Hemodynamic effects of sulmazol (ARL-115 BS), a new vasodilator and positive inotropic agent, in patients with cardiogenic shock.
Simoons ML; Muskens G; Hugenholtz PG
Herz; 1983 Feb; 8(1):34-40. PubMed ID: 6832691
[TBL] [Abstract][Full Text] [Related]
15. Oxygen consumption during septic shock. Effects of inotropic drugs.
Dhainaut JF; Schlemmer B; Monsallier JF; Huyghebaert MF; Brunet F; Villemant D; Carli A
Arch Int Physiol Biochim; 1984 Nov; 92(4):S57-64. PubMed ID: 6085241
[TBL] [Abstract][Full Text] [Related]
16. [Catecholamines in internal medicine emergencies].
Brandt D; Pristautz H; Klein W
Wien Med Wochenschr; 1984 Jul; 134(13-14):324-7. PubMed ID: 6495745
[TBL] [Abstract][Full Text] [Related]
17. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in in situ canine hearts.
Crystal GJ; Zhou X; Gurevicius J; Ramez Salem M
Anesth Analg; 1998 Nov; 87(5):994-1001. PubMed ID: 9806671
[TBL] [Abstract][Full Text] [Related]
18. Dopamine--clinical uses of an endogenous catecholamine.
Goldberg LI
N Engl J Med; 1974 Oct; 291(14):707-10. PubMed ID: 4604342
[No Abstract] [Full Text] [Related]
19. Combined hemodynamic effects of dopamine and dobutamine in cardiogenic shock.
Richard C; Ricome JL; Rimailho A; Bottineau G; Auzepy P
Circulation; 1983 Mar; 67(3):620-6. PubMed ID: 6821904
[TBL] [Abstract][Full Text] [Related]
20. [Basic principles of the therapy of shock].
Schröder R
Minerva Med; 1972 Dec; 63(93):5243-6. PubMed ID: 4646406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
